Acquisition of CorHepta - Summary of Rollforward the Contingent Consideration Related to the Acquisition (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Business Combination [Abstract] | ||||
| Balance, beginning | $ 0 | $ 2,912,159 | $ 3,061,501 | $ 0 |
| Additions | 0 | 0 | 0 | 4,435,443 |
| Issuance of common stock | 0 | 0 | (2,688,147) | 0 |
| Change in fair value | 0 | (492,827) | (373,354) | (2,016,111) |
| Balance, ending | $ 0 | $ 2,419,332 | $ 0 | $ 2,419,332 |
| X | ||||||||||
- Definition Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of increase in indefinite-lived asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes goodwill. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|